Do BPC-157 TB-500 have systemic or localized effects
KPV, the C-terminal tripeptide of -MSH (Lys-Pro-Val), has been investigated for its interaction with NF-B signaling, with researchers observing inhibition of NF-B nuclear translocation and downstream inflammatory cytokine expression (TNF-, IL-6, IL-8) in cell culture models
Side effects depend on the peptide, dose, product quality, route, health history, and other medications
Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control. AAPS Journal
This therapy is ideal for individuals with osteoarthritis or musculoskeletal injuries who cannot tolerate corticosteroid injections, have contraindications to steroids, or have not experienced relief from prior steroid or viscosupplementation treatments